Beyond ADMET: AI for medicines safety - survey
Imported from official source
The MHRA and the Regulatory Innovation Office (RIO) invite organisations to share their views on the use of artificial intelligence (AI) in medicines development.
This version
- Version
- 1 of 1
- Recorded
- September 22, 2026 10:30
- Change
- Initial
- Content hash
d68bc659d65c6d4c8cd2a28cbba84eaf- All versions
- Revision history